CT Scanners Market in China 2023

CT Scanners Market in China 2023

CT scanners combine X-ray imaging with computed tomography to generate cross-sectional images of the human body. They are widely used in healthcare facilities to produce valuable scans for diagnosing and treating tumor diseases. These images can be combined to construct 3D visualizations of specific body areas.

CT scanners differ in the number of slices or data sections obtained per 360-degree rotation. Models with higher slice counts have more detector rows, allowing greater coverage and faster scan times. However, high-slice CT scanners are typically more expensive than low-slice versions.

In certain applications like cardiac CT, high-slice models produce more accurate results. The large number of thinner slices provides higher resolution and the ability to reconstruct detailed 3D views of complex organs like the heart. This aids in precisely identifying abnormalities and planning surgical interventions.

Per data, the market was valued at RMB 16.9 billion in 2022. In 2020, COVID-19 drove CT demand, enlarging market scale by 29.3% to RMB 15.0 billion. Influenced by changes in price, volume and product mix, it is projected to reach RMB 29.3 billion by 2027, reflecting a CAGR of 11.6%.

The aging population, rising disposable incomes, and greater public awareness of disease prevention and diagnosis are fueling demand for safe, accurate and timely diagnostic capabilities. Compared to invasive diagnostic methods like biopsies, medical imaging provides a safer alternative that avoids complications and reduces hospitalization needs. In many applications, medical imaging remains the only technology that allows physicians to obtain visual representations of a patient's anatomical structure and pathophysiology. This is critical for examination, diagnosis of diseases, and development of treatment plans.

China's CT industry faces high technological barriers. Overall capabilities of local manufacturers still lag global leaders, with the market dominated by multinationals currently. Participants comprise three tiers:

First-tier global majors like GE, Philips and Siemens leverage extensive product lines, performance edge and brand equity to lead premium segments.

Second-tier domestic firms like Neusoft Medical Systems, United Imaging Healthcare, Anke High-tech and MinFound Medical have initial high-end CT capabilities but lack broad acceptance.

Third-tier players concentrate in low-end with modest shares.